Get the app!
Back to Trades
Grant4

Denali Therapeutics Inc.

DNLI

Total Value
$475.9K

Company Information

Ticker Symbol
DNLI
CIK
0001714899

Insider Information

Role
Director
Location
SOUTH SAN FRANCISCO, CA

Filing Details

Filing Date
Nov 6, 2025
Transaction Date
Nov 4, 2025
Accession Number
0001816206-25-000007
Form Type
4

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.